| December 2018

Patient Preferences for the FDA

Client

Global pharma company

Respondents

n=1,000 people
with type 1 diabetes

Segmented by A1c, CGM use, insulin delivery method

Methods

Online community, in-person dyad interviews, conjoint analysis

Qualitative research followed by quantitative conjoint study.